The PBM Transparency Act Will Not Lower Drug Prices

While members of Congress agree on the need to try to rein in the prices of prescription drugs, there is less consensus as to how this might be accomplished. Unfortunately, some of the ideas currently...

The FTC’s Fight Against Non-Monopolies Won’t Help Consumers

Popular Bloomberg News columnist Matt Levine likes to make a comical point in his popular Moneystuff column for Bloomberg that from the SEC’s perspective nearly everything a company does (or its execu...

Pharmacy Benefit Managers Are The Wrong Target In Biden’s Quest To Reduce Drug Prices

Prescription drug prices remain high despite the fact that the Biden Administration—and its predecessors—have declared reducing prices as a top priority, and the public has been demanding action on th...